Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Bruening W, Sullivan N, Carter Paulson E, Zafar H, Mitchell M, Treadwell J, Schoelles K. Imaging tests for the staging of colorectal cancer. Rockville: Agency for Healthcare Research and Quality (AHRQ). Comparative Effectiveness Review No.142. 2014 Authors' objectives Colorectal cancer is both the third most common type of cancer and the third most common cause of cancer-related death for both men and women. Treatment options for colorectal cancer differ depending on the clinical stage of disease at diagnosis. Our objective was to synthesize the available evidence on the comparative effectiveness of imaging tests for staging colorectal cancer. Authors' conclusions ERUS is preferable to CT for preoperative rectal cancer T staging (based on evidence of low strength). Moderate-strength evidence suggests MRI is preferable to CT for detecting colorectal liver metastases. Low-strength evidence suggests that CT, MRI, and ERUS are comparable for rectal cancer N staging, where all have limited sensitivity, and for interim rectal cancer T restaging. Evidence was insufficient to allow any evidence-based conclusions about the use of PET/CT for colorectal cancer staging Indexing Status Subject indexing assigned by CRD MeSH Colorectal Neoplasmss; Diagnostic Imaging; Neoplasm Staging Language Published English Country of organisation United States English summary An English language summary is available. Address for correspondence AHRQ, Center for Outcomes and Evidence Technology Assessment Program, 540 Gaither Road, Rockville, MD 20850, USA Email: AHRQTAP@ahrq.hhs.gov AccessionNumber 32014001112 Date abstract record published 06/10/2014 |